CIK: 1398940 - Address: C/O Protagonist Therapeutics, Inc., 7707 Gateway Blvd., Suite 140, Newark, CA 94560-1160
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/19/24 18:49
11/15/24
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsMolina Arturo MdCAOChief MeS-7840.980-2-446D
1/4/24 20:09
11/15/23
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsMolina Arturo MdCAOChief MeS.d-3016.240-2-449D
3/7/22 19:20
3/5/22
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagMolina Arturo MdCAOChief MeM.d00.000135038D
2/1/22 20:36
1/29/22
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagMolina Arturo MdCAOChief MeM.d00.00052230D
9/28/21 18:57
9/24/21
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagMolina Arturo MdCAOChief MeM.d00.00094826D
2/1/21 17:55
1/29/21
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagMolina Arturo MdCAOChief MeM.d00.00053421D
9/28/20 17:56
9/25/20
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagMolina Arturo MdCAOChief MeM.d00.00099518D
5/14/20 17:27
5/14/20
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagMolina Arturo MdCAOChief MeP507.750611512D
9/30/19 17:25
9/26/19
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagMolina Arturo MdCAOChief MeM.d00.00096D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact